EUVIMEDEUVIMED entdecken
Crossref

Feasibility of measuring comorbidity indices based on clinical breast cancer records

Bita Eslami, Sadaf Alipour, Monireh S Seyyedsalehi, Azin Nahvijou, Ramesh Omranipour, Mojtaba V Rajabpour, Kazem Zendehdel

Eastern Mediterranean Health Journal · 30.11.2023 · 29 (11) · 870-876

DOI: 10.26719/emhj.23.091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 30.11.2023. Verfasst von Bita Eslami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Breast Diseases Research Center, Cancer Institute, Tehran University of Medical Science, Tehran, Islamic Republic of Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Vital Statistics. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comorbidities have a significant impact on the treatment and outcome of breast cancer. However, data on such comorbidities from low-income countries are limited.

Aim

To evaluate the feasibility and accuracy of comorbidity data extracted from medical records for estimating the prevalence of comorbidities among patients registered in the clinical breast cancer registry of the Islamic Republic of Iran.

Methods

We collected data from the medical records of 400 patients on 30 comorbidities included in the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI). The sensitivity and specificity of comorbidity data extracted from medical records were calculated using data from interviews with 97 randomly selected patients. We studied the prevalence of comorbidities using the CCI and ECI. Data were analysed using SPSS version 24.

Results

The mean age of patients was 51.69 SD 12.28 years. The sensitivity and specificity of medical records for detecting any comorbidity data contained in CCI versus non-comorbidity were 93.2% and 69.8%, respectively. However, for the comorbidity data included in ECI, both sensitivity (86.9%) and specificity (44.4%) were lower than in CCI. Hypertension (n = 144, 36.0%) and diabetes without chronic complications (n = 77, 19.3%) were the most prevalent comorbidities. A higher proportion of patients had no comorbidity with CCI (72.2%) than with ECI (44.8%).

Conclusion

It is feasible to construct a comorbidity index using medical records with high accuracy, especially when we extract comorbidities using the CCI. Further studies are needed to understand the association between comorbidity index and breast cancer survival among Iranian patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsVital StatisticsHumansMiddle AgedFemaleFeasibility StudiesIranComorbidityRetrospective Studies

Stichwörter der Autor:innen

Charlson Comorbidity IndexElixhauser Comorbidity IndexIranbreast cancercancer registry

Autor:innen und Institutionen

  • Breast Diseases Research Center, Cancer Institute, Tehran University of Medical Science, Tehran, Islamic Republic of Iran.
  • Department of Surgery, Arash Women's Hospital, Tehran University of Medical Science, Tehran, Islamic Republic of Iran.
  • Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Zitieren

APA

Eslami, B., Alipour, S., Seyyedsalehi, M. S., Nahvijou, A., Omranipour, R., Rajabpour, M. V., & Zendehdel, K. (2023). Feasibility of measuring comorbidity indices based on clinical breast cancer records. Eastern Mediterranean Health Journal, 29(11), 870-876. https://doi.org/10.26719/emhj.23.091

Vancouver

Eslami B, Alipour S, Seyyedsalehi MS, Nahvijou A, Omranipour R, Rajabpour MV, et al. Feasibility of measuring comorbidity indices based on clinical breast cancer records. Eastern Mediterranean Health Journal. 2023;29(11):870-876. doi:10.26719/emhj.23.091

BibTeX
@article{Eslami2023,
  author = {Eslami, Bita and Alipour, Sadaf and Seyyedsalehi, Monireh S and Nahvijou, Azin and Omranipour, Ramesh and Rajabpour, Mojtaba V and Zendehdel, Kazem},
  title = {Feasibility of measuring comorbidity indices based on clinical breast cancer records},
  journal = {Eastern Mediterranean Health Journal},
  year = {2023},
  volume = {29},
  number = {11},
  pages = {870--876},
  doi = {10.26719/emhj.23.091}
}
Kostenlos starten →